Osteogenin (bone morphogenic protein 3) inhibits proliferation and stimulates differentiation of osteoprogenitors in human bone marrow
Open Access
- 1 January 1995
- journal article
- Published by Elsevier in Differentiation
- Vol. 58 (2), 157-164
- https://doi.org/10.1046/j.1432-0436.1995.5820157.x
Abstract
No abstract availableThis publication has 44 references indexed in Scilit:
- Polypeptide Growth Factors in Bone MatrixPublished by Wiley ,2007
- Transforming growth factor-beta: Its effect on phenotype reexpression by dedifferentiated chondrocytes in the presence and absence of osteogeninIn Vitro Cellular & Developmental Biology – Animal, 1992
- Initiation and progression of mineralization of bone nodules formed in vitro: the role of alkaline phosphatase and organic phosphateBone and Mineral, 1991
- Osteogenin promotes reexpression of cartilage phenotype by dedifferentiated articular chondrocytes in serum-free mediumExperimental Cell Research, 1991
- Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone.Proceedings of the National Academy of Sciences, 1990
- The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2Biochemical and Biophysical Research Communications, 1990
- Factors that promote progressive development of the osteoblast phenotype in cultured fetal rat calvaria cellsJournal of Cellular Physiology, 1990
- Insulin like growth factor I hormonal regulation by growth hormone and by 1,25(OH)2D3 and activity on human osteoblast-like cells in short-term culturesBone, 1990
- 1,25-Dihydroxyvitamin D3and Human Bone-Derived Cells in Vitro: Effects on Alkaline Phosphatase, Type I Collagen and Proliferation*Endocrinology, 1986
- Estimation of bone turnover evaluated by 47Ca-kinetics. Efficiency of serum bone gamma-carboxyglutamic acid-containing protein, serum alkaline phosphatase, and urinary hydroxyproline excretion.JCI Insight, 1985